Adeno-Associated Virus Serotype 9 Transduction in the Central Nervous System of Nonhuman Primates
Citations Over TimeTop 1% of 2011 papers
Abstract
Widespread distribution of gene products at clinically relevant levels throughout the CNS has been challenging. Adeno-associated virus type 9 (AAV9) vector has been reported as a good candidate for intravascular gene delivery, but low levels of preexisting antibody titers against AAV in the blood abrogate cellular transduction within the CNS. In the present study we compared the effectiveness of vascular delivery and cerebrospinal fluid (CSF) delivery of AAV9 in transducing CNS tissue in nonhuman primates. Both delivery routes generated similar distribution patterns, although we observed a more robust level of transduction after CSF delivery. Consistent with previous reports administering AAV9, we found greater astrocytic than neuronal tropism via both routes, although we did find a greater magnitude of CNS transduction after CSF delivery compared with intravascular delivery. Last, we have demonstrated that delivery of AAV9 into the CSF does not shield against AAV antibodies. This has obvious implications when developing and/or implementing any clinical trial studies.
Related Papers
- → In vivo tissue-tropism of adeno-associated viral vectors(2016)347 cited
- → An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism(2004)70 cited
- → Adenovirus 5 Fibers Mutated at the Putative HSPG-binding Site Show Restricted Retargeting with Targeting Peptides in the HI Loop(2007)63 cited
- → Pseudotyped adeno‐associated viral vector tropism and transduction efficiencies in murine wound healing(2012)22 cited
- → A novel system to study adenovirus tropism to normal and malignant colon tissues(2006)19 cited